Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. 130 Brookline Street, Suite 201 Cambridge, MA 20139
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1652130

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	5/22/2024	USPTO Trademark Trial and Appeal Board	91291636-OPP	Intellia Therapeutics, Inc. v. Fresenius Medical Care Holdin...	Plaintiff
	2/15/2024	USPTO Trademark Trial and Appeal Board	97835989-EXT	Intellia Therapeutics, Inc. v. Fresenius Medical Care Holdin...	Potential Opposer

2 Rows Total

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (10)

	Last Name	First Name	Middle Name	Firm	Location
	Bonner	Julie
	Chang	Audrey		Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Drury	Kathleen			Cambridge, MA
	Galvis	Geraldine
	Gelchinsky	Jonathan	M.
	JACQUIN	ANDREA			East Hanover, NJ
	Merlilno	Juliana			CAMBRIDGE, MA
	Merlino	Mrs.	Juliana		CAMBRIDGE, MA
	Merlino	Juliana			CAMBRIDGE, MA

10 Rows Total

Filter By Form All Records 10-K 10-K/A 10-Q 10-Q/A 3 4 4/A 424B4 424B5 5 8-A12B 8-K CERTNAS CORRESP CT ORDER D DEF 14A DRS DRS/A EFFECT FWP POS AM POSASR S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD From To

	Date	Entity	Form Number	Description
	11/10/2025		8-K	Current report pursuant to Section 13 or 15(d)
	11/6/2025		8-K	Current report pursuant to Section 13 or 15(d)
	11/6/2025		10-Q
	11/4/2025		SCHEDULE 13G/A
	10/29/2025		8-K	Current report pursuant to Section 13 or 15(d)
	10/27/2025		8-K	Current report pursuant to Section 13 or 15(d)
	10/3/2025	Schultes, Birgit C.	4	Statement of changes in beneficial ownership of securities
	10/3/2025	Dube Michael P	4	Statement of changes in beneficial ownership of securities
	9/25/2025		8-K	Current report pursuant to Section 13 or 15(d)
	8/22/2025	Chase William J	4	Statement of changes in beneficial ownership of securities
	8/7/2025		8-K	Current report pursuant to Section 13 or 15(d)
	8/7/2025		10-Q
	7/25/2025	Dulac Edward J III	4	Statement of changes in beneficial ownership of securities
	7/3/2025	Clark, Eliana	4	Statement of changes in beneficial ownership of securities
	7/3/2025	Dube Michael P	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Goodman, Jesse	4	Statement of changes in beneficial ownership of securities
	6/18/2025	Keresty Georgia	4	Statement of changes in beneficial ownership of securities
	6/16/2025		8-K	Current report pursuant to Section 13 or 15(d)
	6/13/2025	Verwiel Frank	4	Statement of changes in beneficial ownership of securities
	6/13/2025	Goodman, Jesse	4	Statement of changes in beneficial ownership of securities
	6/13/2025	Goff, Brian	4	Statement of changes in beneficial ownership of securities
	6/13/2025	Bhanji Muna	4	Statement of changes in beneficial ownership of securities
	6/13/2025	Chase William J	4	Statement of changes in beneficial ownership of securities
	6/13/2025	Cohen, Fred E.	4	Statement of changes in beneficial ownership of securities
	6/12/2025		8-K	Current report pursuant to Section 13 or 15(d)
	6/11/2025		S-8
	5/28/2025		8-K	Current report pursuant to Section 13 or 15(d)
	5/19/2025		8-K	Current report pursuant to Section 13 or 15(d)
	5/13/2025		SCHEDULE 13G
	5/8/2025		8-K	Current report pursuant to Section 13 or 15(d)
	5/8/2025		10-Q
	5/1/2025	Bhanji Muna	4	Statement of changes in beneficial ownership of securities
	4/30/2025		DEFA14A
	4/30/2025		DEF 14A
	4/30/2025		ARS
	4/17/2025		SCHEDULE 13G/A
	4/7/2025		8-K	Current report pursuant to Section 13 or 15(d)
	3/4/2025	Clark, Eliana	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Leonard, John M.	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Dulac Edward J III	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Dube Michael P	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Lebwohl, David	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Schultes, Birgit C.	4	Statement of changes in beneficial ownership of securities
	3/4/2025	Basta James	4	Statement of changes in beneficial ownership of securities
	2/28/2025		S-8
	2/27/2025		8-K	Current report pursuant to Section 13 or 15(d)
	2/27/2025		10-K	Annual report pursuant to Section 13 or 15(d)
	2/21/2025		8-K	Current report pursuant to Section 13 or 15(d)
	1/31/2025	Bhanji Muna	4	Statement of changes in beneficial ownership of securities
	1/23/2025	Schultes, Birgit C.	3	Initial statement of beneficial ownership of securities

647 Rows Total	Page 1 of 13 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	4/24/2025	Strapps, Walter	Assignor	Application Publication	18941127 20250059532	Modified Guide RNAs Modified Guide RNAs
	4/24/2025	Morrissey, David V.	Assignor	Application Publication	18941127 20250059532	Modified Guide RNAs Modified Guide RNAs
	4/24/2025	Smith, Amy Madison Rhoden	Assignor	Application Publication	18941127 20250059532	Modified Guide RNAs Modified Guide RNAs
	3/5/2025	Kanjolia, Arti Mahendra Prakash	Assignor	Application Application Publication Publication	18704681 18704681 20240415980 20240415980	Crispr/cas-related Methods And Compositions For Knocking Out C5 Crispr/cas-related Methods And Compositions For Knocking Out C5
	3/5/2025	Hesse, Sarah	Assignor	Application Application Publication Publication	18704681 18704681 20240415980 20240415980
	3/5/2025	Regeneron Pharmaceuticals, Inc.	Assignee	Application Application Publication Publication	18704681 18704681 20240415980 20240415980	Crispr/cas-related Methods And Compositions For Knocking Out C5 Crispr/cas-related Methods And Compositions For Knocking Out C5 Crispr/cas-related Methods And Compositions For Knocking Out C5 Crispr/cas-related Methods And Compositions For Knocking Out C5
	12/12/2024	Rudulier, Christopher	Assignor	Application Application Publication Publication	18270261 18270261 20240316100 20240316100	Engineered T Cells Engineered T Cells
	11/18/2024	Maetani, Micah	Assignor	Application Publication	18796047 20250074866	Modified Amine Lipids Modified Amine Lipids
	11/18/2024	Scully, Stephen S.	Assignor	Application Publication	18796047 20250074866	Modified Amine Lipids Modified Amine Lipids
	11/18/2024	Majzoub, Ramsey	Assignor	Application Publication	18796047 20250074866	Modified Amine Lipids Modified Amine Lipids
	9/5/2024	Forget, Anthony	Assignor	Application Publication	18835246 20250032642	Crispr-mediated Transgene Insertion In Neonatal Cells Crispr-mediated Transgene Insertion In Neonatal Cells
	9/5/2024	Regeneron Pharmaceuticals, Inc.	Assignee	Application Publication	18835246 20250032642
	9/5/2024	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication	18835246 20250032642
	8/1/2024	Forget, Anthony	Assignor	Application Publication	18835246 20250032642	Crispr-mediated Transgene Insertion In Neonatal Cells Crispr-mediated Transgene Insertion In Neonatal Cells
	8/1/2024	Regeneron Pharmaceuticals, Inc.	Assignee	Application Publication	18835246 20250032642	Crispr-mediated Transgene Insertion In Neonatal Cells Crispr-mediated Transgene Insertion In Neonatal Cells
	8/1/2024	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication	18835246 20250032642	Crispr-mediated Transgene Insertion In Neonatal Cells Crispr-mediated Transgene Insertion In Neonatal Cells
	6/21/2024	Cook, Danielle Ryan	Assignor	Application Publication	18585231 20240228577	Programmed Cell Death Protein 1 (PD1) Compositions and Methods for Cell-... Programmed Cell Death Protein 1 (PD1) Compositions and Methods for Cell-...
	6/18/2024	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication	17233373 20220354967
	6/18/2024	Regeneron Pharmaceuticals, Inc.	Assignee	Application Publication	17233373 20220354967
	6/18/2024	Huang, Hon-ren	Assignor	Application Publication	17233373 20220354967
	6/18/2024	Finn, Jonathan Douglas	Assignor	Application Publication	17233373 20220354967
	6/18/2024	Roy, Moitri	Assignor	Application Publication	17233373 20220354967
	5/30/2024	Murray, Bradley Andrew	Assignor	Application Publication	18415032 20250025580	Compositions and Methods for Treatment of Diseases Associated with Trinu... Compositions and Methods for Treatment of Diseases Associated with Trinu...
	5/30/2024	Burns, Sean Michael	Assignor	Application Publication	18415032 20250025580	Compositions and Methods for Treatment of Diseases Associated with Trinu... Compositions and Methods for Treatment of Diseases Associated with Trinu...
	5/30/2024	Hesse, Sarah Beth	Assignor	Application Publication	18415032 20250025580	Compositions and Methods for Treatment of Diseases Associated with Trinu... Compositions and Methods for Treatment of Diseases Associated with Trinu...
	11/6/2023	Swami, Archana	Assignor	Application Publication	18287229 20240200106	Lipid Nanoparticles Compositions Lipid Nanoparticles Compositions
	11/6/2023	Maetani, Micah	Assignor	Application Publication	18287229 20240200106	Lipid Nanoparticles Compositions Lipid Nanoparticles Compositions
	11/6/2023	Prodeus, Aaron	Assignor	Application Publication	18287229 20240200106	Lipid Nanoparticles Compositions Lipid Nanoparticles Compositions
	11/6/2023	Parmar, Rubina Giare	Assignor	Application Publication	18287229 20240200106	Lipid Nanoparticles Compositions Lipid Nanoparticles Compositions
	11/6/2023	Rakshe, Vishal	Assignor	Application Publication	18287229 20240200106	Lipid Nanoparticles Compositions Lipid Nanoparticles Compositions
	11/6/2023	Swami, Archana	Assignor	Application Publication	18287239 20250090471	Lipid Nanoparticle Compositions Lipid Nanoparticle Compositions
	11/6/2023	Maetani, Micah	Assignor	Application Publication	18287239 20250090471	Lipid Nanoparticle Compositions Lipid Nanoparticle Compositions
	11/6/2023	Prodeus, Aaron	Assignor	Application Publication	18287239 20250090471	Lipid Nanoparticle Compositions Lipid Nanoparticle Compositions
	11/6/2023	Parmar, Rubina Giare	Assignor	Application Publication	18287239 20250090471	Lipid Nanoparticle Compositions Lipid Nanoparticle Compositions
	11/6/2023	Rakshe, Vishal	Assignor	Application Publication	18287239 20250090471	Lipid Nanoparticle Compositions Lipid Nanoparticle Compositions
	10/24/2023	Cook, Danielle Ryan	Assignor	Application Publication	18366051 20230383252	Natural Killer Cell Receptor 2B4 Compositions and Methods for Immunother... Natural Killer Cell Receptor 2B4 Compositions and Methods for Immunother...
	10/24/2023	Odate, Shobu	Assignor	Application Publication	18362675 20240018496	Compositions and Methods for Kallikrein (KLKB1) Gene Editing Compositions and Methods for Kallikrein (KLKB1) Gene Editing
	10/24/2023	Seitzer, Jessica Lynn	Assignor	Application Publication	18362675 20240018496	Compositions and Methods for Kallikrein (KLKB1) Gene Editing Compositions and Methods for Kallikrein (KLKB1) Gene Editing
	10/24/2023	Zhang, Yong	Assignor	Application Publication	18339665 20240024478	Compositions and Methods for Reducing HLA-A in a Cell Compositions and Methods for Reducing HLA-A in a Cell
	10/24/2023	Murray, Bradley Andrew	Assignor	Application Publication	18339665 20240024478	Compositions and Methods for Reducing HLA-A in a Cell Compositions and Methods for Reducing HLA-A in a Cell
	10/24/2023	Lescarbeau, Reynald Michael	Assignor	Application Publication	18339665 20240024478	Compositions and Methods for Reducing HLA-A in a Cell Compositions and Methods for Reducing HLA-A in a Cell
	10/24/2023	Sridhar, Srijani	Assignor	Application Publication	18339665 20240024478	Compositions and Methods for Reducing HLA-A in a Cell Compositions and Methods for Reducing HLA-A in a Cell
	10/24/2023	Goel, Surbhi	Assignor	Application Publication	18339665 20240024478	Compositions and Methods for Reducing HLA-A in a Cell Compositions and Methods for Reducing HLA-A in a Cell
	7/12/2023	Zhang, Yong	Assignor	Application Publication	18332390 20240016934	Compositions and Methods for Reducing MHC Class II in a Cell Compositions and Methods for Reducing MHC Class II in a Cell
	7/12/2023	Sridhar, Srijani	Assignor	Application Publication	18332390 20240016934	Compositions and Methods for Reducing MHC Class II in a Cell Compositions and Methods for Reducing MHC Class II in a Cell
	7/12/2023	Harrington, William Frederick	Assignor	Application Publication	18332390 20240016934	Compositions and Methods for Reducing MHC Class II in a Cell Compositions and Methods for Reducing MHC Class II in a Cell
	7/12/2023	Goel, Surbhi	Assignor	Application Publication	18332390 20240016934	Compositions and Methods for Reducing MHC Class II in a Cell Compositions and Methods for Reducing MHC Class II in a Cell
	5/16/2023	Forget, Anthony	Assignor	Application Publication	18163698 20230338477	Anti-tfr:gaa And Anti-cd63:gaa Insertion For Treatment Of Pompe Disease Anti-tfr:gaa And Anti-cd63:gaa Insertion For Treatment Of Pompe Disease
	5/16/2023	Regeneron Pharmaceuticals, Inc.	Assignee	Application Publication	18163698 20230338477	Anti-tfr:gaa And Anti-cd63:gaa Insertion For Treatment Of Pompe Disease Anti-tfr:gaa And Anti-cd63:gaa Insertion For Treatment Of Pompe Disease
	5/2/2023	Dombrowski, Christian	Assignor	Application Publication	18310298 20230271997	Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA) Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA)
	3/2/2023	Strapps, Walter	Assignor	Application Publication Patent	17900960 20230287400 12173284	Modified Guide RNAs Modified Guide RNAs Modified Guide RNAs
	3/2/2023	Morrissey, David V.	Assignor	Application Publication Patent	17900960 20230287400 12173284	Modified Guide RNAs Modified Guide RNAs Modified Guide RNAs
	3/2/2023	Smith, Amy Madison Rhoden	Assignor	Application Publication Patent	17900960 20230287400 12173284	Modified Guide RNAs Modified Guide RNAs Modified Guide RNAs
	2/21/2023	Strapps, Walter	Assignor	Application Publication Patent	18064086 20230118592 11795460	Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido...
	2/21/2023	Odate, Shobu	Assignor	Application Publication Patent	18064086 20230118592 11795460	Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido...
	2/21/2023	Lescarbeau, Reynald Michael	Assignor	Application Publication Patent	18064086 20230118592 11795460	Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido...
	2/21/2023	Kanjolia, Arti Mahendra Prakash	Assignor	Application Publication Patent	18064086 20230118592 11795460	Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido...
	2/21/2023	Seitzer, Jessica Lynn	Assignor	Application Publication Patent	18064086 20230118592 11795460	Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido... Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloido...
	3/23/2022	Maetani, Micah	Assignor	Application Publication	17605780 20220402862	Ionizable Amine Lipids And Lipid Nanoparticles Ionizable Amine Lipids And Lipid Nanoparticles
	3/23/2022	Parmar, Rubina Giare	Assignor	Application Publication	17605780 20220402862	Ionizable Amine Lipids And Lipid Nanoparticles Ionizable Amine Lipids And Lipid Nanoparticles
	3/23/2022	Scully, Stephen S.	Assignor	Application Publication	17605780 20220402862	Ionizable Amine Lipids And Lipid Nanoparticles Ionizable Amine Lipids And Lipid Nanoparticles
	3/23/2022	Laplaca, Derek	Assignor	Application Publication	17605780 20220402862	Ionizable Amine Lipids And Lipid Nanoparticles Ionizable Amine Lipids And Lipid Nanoparticles
	3/23/2022	Pelly, Rachel	Assignor	Application Publication	17605780 20220402862	Ionizable Amine Lipids And Lipid Nanoparticles Ionizable Amine Lipids And Lipid Nanoparticles
	12/30/2021	Maetani, Micah	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/30/2021	Scully, Stephen S.	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/30/2021	Majzoub, Ramsey	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/30/2021	Maetani, Micah	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	12/30/2021	Scully, Stephen S.	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	12/30/2021	Majzoub, Ramsey	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Maetani, Micah	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Scully, Stephen S.	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Majzoub, Ramsey	Assignor	Application Publication	17299925 20220119341	Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Maetani, Micah	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Scully, Stephen S.	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	12/22/2021	Majzoub, Ramsey	Assignor	Application Publication Patent	17299925 20220119341 12077483	Modified Amine Lipids Modified Amine Lipids Modified Amine Lipids
	6/4/2021	Maetani, Micah	Assignor	Application Publication	17282157 20220009878	Ionizable Amine Lipids Ionizable Amine Lipids
	6/4/2021	Parmar, Rubina Giare	Assignor	Application Publication	17282157 20220009878	Ionizable Amine Lipids Ionizable Amine Lipids
	6/4/2021	Scully, Stephen S.	Assignor	Application Publication	17282157 20220009878	Ionizable Amine Lipids Ionizable Amine Lipids
	6/4/2021	Laplaca, Derek	Assignor	Application Publication	17282157 20220009878	Ionizable Amine Lipids Ionizable Amine Lipids
	3/16/2021	Brown, Robert	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Roy, Matthew	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Seitzer, Jessica	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Lescarbeau, Reynald Michael	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Alexander, Seth C.	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Salerno, Paige	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Lescarbeau, Rebecca	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Lanba, Adhiraj	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Smith, Amy Madison Rhoden	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Brown, Duncan	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	3/16/2021	Parmar, Rubina G.	Assignor	Application Publication	17111769 20210087568	Modified Guide RNAs for Gene Editing Modified Guide RNAs for Gene Editing
	2/22/2021	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication	16657961 20200289628	Compositions And Methods For Expressing Factor Ix Compositions And Methods For Expressing Factor Ix
	2/22/2021	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication	16657944 20200270617	Compositions And Methods For Transgene Expression From An Albumin Locus Compositions And Methods For Transgene Expression From An Albumin Locus
	2/22/2021	Regeneron Pharmaceuticals, Inc.	Assignor	Application Publication Application	16657961 20200289628 12214023	Compositions And Methods For Expressing Factor Ix Compositions And Methods For Expressing Factor Ix
	2/17/2021	Huang, Hon-ren	Assignor	Application Publication	16657939 20200268906	Nucleic Acid Constructs And Methods Of Use Nucleic Acid Constructs And Methods Of Use
	2/17/2021	Finn, Jonathan Douglas	Assignor	Application Publication	16657939 20200268906	Nucleic Acid Constructs And Methods Of Use Nucleic Acid Constructs And Methods Of Use
	2/17/2021	Huang, Hon-ren	Assignor	Application Publication	16657944 20200270617	Compositions And Methods For Transgene Expression From An Albumin Locus Compositions And Methods For Transgene Expression From An Albumin Locus
	2/17/2021	Finn, Jonathan Douglas	Assignor	Application Publication	16657944 20200270617	Compositions And Methods For Transgene Expression From An Albumin Locus Compositions And Methods For Transgene Expression From An Albumin Locus
	2/17/2021	Roy, Moitri	Assignor	Application Publication	16657944 20200270617	Compositions And Methods For Transgene Expression From An Albumin Locus Compositions And Methods For Transgene Expression From An Albumin Locus
	2/17/2021	Huang, Hon-ren	Assignor	Application Publication	16657961 20200289628	Compositions And Methods For Expressing Factor Ix Compositions And Methods For Expressing Factor Ix
	2/17/2021	Finn, Jonathan Douglas	Assignor	Application Publication	16657961 20200289628	Compositions And Methods For Expressing Factor Ix Compositions And Methods For Expressing Factor Ix
	2/17/2021	Roy, Moitri	Assignor	Application Publication	16657961 20200289628	Compositions And Methods For Expressing Factor Ix Compositions And Methods For Expressing Factor Ix
	2/17/2021	Regeneron Pharmaceuticals, Inc.	Assignee	Application Publication	16657939 20200268906	Nucleic Acid Constructs And Methods Of Use Nucleic Acid Constructs And Methods Of Use

102 Rows Total

Intellia Therapeutics, Inc. has not been involved in any trademark assignment transactions in the PlainSite database.

Competitors (0)

There are no organizations to display.

Corporate Family (41)

Track Corporate Family

• Atlas Venture Associates IX, LLC, None
• Baker Bros. Advisors (GP) LLC, None
• Baker Felix, None
• Barnes, Thomas M., None
• Basta James, None
• Bell, Graeme, None
• Bermingham, Nessan, None
• Bhanji Muna, None
• Caribou Biosciences, Inc., None
• Chase William J, None
• Clark, Eliana, None
• Cohen, Fred E., None
• Crowley, John F., None
• Dorsa Caroline, None
• Dube Michael P, None
• Dulac Edward J III, None
• Formela Jean Francois, None
• Goddard Glenn, None
• Goff, Brian, None
• Goodman, Jesse, None
• Gordon Carl L, None
• Haurwitz, Rachel E., None
• Heifner Nicole, None
• Hicks Derek, None
• Isaly Samuel D, None
• Karsen Perry A, None
• Keresty Georgia, None
• Lebwohl, David, None
• Leonard, John M., None
• Morrissey, David V., None
• Novartis AG, None
• Novartis Institutes for BioMedical Research, Inc., None
• Rivera, Jose E., None
• Schiermeier Andrew, None
• Schultes, Birgit C., None
• Sepp-lorenzino, Laura, None
• Slaoui, Moncef, None
• Srivastava Sapna, None
• Tananbaum, James B., None
• TLS Beta Pte. Ltd., None
• Verwiel Frank, None

Subsidiaries

• Dorsa Caroline
• Karsen Perry A
• Haurwitz, Rachel E.
• Gordon Carl L
• Formela Jean Francois
• Bermingham, Nessan
• Caribou Biosciences, Inc.
• Novartis AG
• Atlas Venture Associates IX, LLC
• Baker Bros. Advisors (GP) LLC
• TLS Beta Pte. Ltd.
• Isaly Samuel D
• Bell, Graeme
• Rivera, Jose E.
• Leonard, John M.
• Barnes, Thomas M.
• Morrissey, David V.
• Heifner Nicole
• Slaoui, Moncef
• Verwiel Frank
• Novartis Institutes for BioMedical Research, Inc.
• Schiermeier Andrew
• Goodman, Jesse
• Goddard Glenn
• Cohen, Fred E.
• Sepp-lorenzino, Laura
• Lebwohl, David
• Crowley, John F.
• Tananbaum, James B.
• Srivastava Sapna
• Baker Felix
• Keresty Georgia
• Hicks Derek
• Basta James
• Clark, Eliana
• Bhanji Muna
• Chase William J
• Dube Michael P
• Goff, Brian
• Dulac Edward J III
• Schultes, Birgit C.

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.